Researcher Next
Create account
← Back to directory

Tony Mok

Researcher Next ID · RN-014464

Researcher · Medicine

Chinese University of Hong Kong

, Hong Kong

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
1,093
Citation count
108,819
H-index
130
i10-index
492

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Lung Cancer Treatments and Mutations
Lung Cancer Research Studies
Lung Cancer Diagnosis and Treatment
Cancer Immunotherapy and Biomarkers
Cancer Genomics and Diagnostics

Publications

  • Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

    The Lancet · 2019 · 10.1016/s0140-6736(18)32409-7

  • First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

    New England Journal of Medicine · 2018 · 10.1056/nejmoa1809064

  • Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer

    New England Journal of Medicine · 2013 · 10.1056/nejmoa1214886

  • Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

    New England Journal of Medicine · 2009 · 10.1056/nejmoa0810699

  • MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

    Science · 2007 · 10.1126/science.1141478

Current projects

    No projects listed.